| Specific Title: Assoc./Professor of Diabetes Research with Endowed Chair - Diabetes and Metabolic Disease Focus Location: IU School of Medicine Department: IUSM - Medicine - Endocrinology Campus: IU School of Medicine Indianapolis Position Announcement: The Endocrinology Division, Department of Medicine and the Center for Diabetes and Metabolic Diseases at the Indiana University School of Medicine are seeking a highly motivated and collaborative basic, translational, or clinical diabetes researcher at the rank of Associate/Full Professor with an Endowed Chair. The successful applicant may have a track record of research excellence and funding in a broad range of topics related to diabetes and/or metabolism. This may include a clinical/translational focus in diabetes epidemiology, genetics of diabetes (type 1 or type 2), informatics, innovations in care delivery, health care disparities, or other similar topics. The successful applicant may also have a basic science interest in topics including (but not limited to) the immunology of type 1 diabetes, beta cell biology, peripheral insulin signaling, adipose biology, stem cell biology, or diabetes-associated complications.
Faculty would be joining a vibrant diabetes research community within the IU School of Medicine, which is part of a broader diabetes research ecosystem in Indiana that includes public and private partners. IUSM is the home to the Center for Diabetes and Metabolic Diseases (CDMD), one of 18 NIH P30 funded Diabetes Research Centers. The CDMD provides support for research cores, pilot and feasibility grant funding, and a number of enrichment activities, including an Annual Diabetes Symposium and weekly multidisciplinary seminar series. IUSM diabetes faculty provide leadership to several large national and international multisite networks and studies, including Type 1 Diabetes TrialNet, the Network for Pancreatic Organ Donors with Diabetes (nPOD), the Integrated Islet Distribution Program, the Immune Tolerance Network, the Restoring Insulin Secretion (RISE) study, the Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes (GRADE), the Human Islet Research Network, and the Rare and Atypical Diabetes Network (RADIANT). IUSM is home to the NIH-funded Indiana Clinical and Translational Sciences Institute (CTSI), which is a statewide research partnership between IU, Purdue, and Notre Dame University. IUSM is also affiliated with the prestigious Regenstrief Institute, a national and international leader in patient-centered research and health informatics, and the Indiana Biosciences Research Institute, connecting academic institutions and industry partners in Indiana. Responsibilities:
Maintain and expand a strong, extramurally-funded diabetes research program in translational/clinical diabetes research
Contribute to the academic mission of IU and the CDMD
Be committed to training the next generation of diabetes researchers
Ample opportunities for research and collaboration, including:
The Center for Diabetes and Metabolic Diseases, an NIH-funded P30 Center with state of the art research cores, Pilot and Feasibility program, and Enrichment program. There are currently over 90 members of the Center with research interests that span basic sciences to community-based interventions.
The Indiana Clinical and Translational Sciences Institute (CTSI) was founded in 2008 and is recognized as a statewide institute supported by a Clinical and Translational Science Award from the National Institutes of Health's (NIH) and the National Center for Advancing Translational Science. Indiana CTSI has research partnerships with Indiana University, Purdue University, and the University of Notre Dame and also includes life sciences, businesses and community organizations. Furthermore, Indiana CTSI engages with the public at every level of research from basic science to patient care.
Regenstrief Institute is an internationally respected non-profit medical research organization associated with Indiana University. Regenstrief's Informaticians have created the Indiana Network for Patient Care (INPC), a community-wide health information exchange now including more than 18 hospitals.
Indiana Biosciences Research Institute (IBRI) is an independent, nonprofit discovery science and applied research institute focused on innovation targeting diabetes, cardio-metabolic diseases and poor nutrition. IBRI brings together life sciences companies and research universities to effectively pursue research to improve human health.Indianapolis is the capital and most populous city in the State of Indiana. It is growing economically thanks to a strong corporate base anchored by the life sciences. Indiana is home to one of the largest concentrations of health sciences companies in the nation. Indianapolis has a sophisticated blend of charm and culture with a wonderful balance of business and leisure. The growing residential base is supported by rich amenities and quality of life – the city possesses a variety of professional sports, arts venues and outdoor recreation areas. Residents of this dynamic city, and surrounding suburbs, enjoy leading educational systems and top-ranked universities, paired with a diverse population. Indianapolis International Airport is a top-ranked international airport, being named |
